USPTO serial 99213231
LUMINIQ
Reviewed by CopyMark Law Group
- Filing date
- Status date
- Registration date
- —
- Examiner
- RICHARDSON, REBEKAH P
- Law office
- TMO LAW OFFICE 134
What this means
These status codes mean the trademark application is abandoned and no longer pending. Common reasons include missing an Office Action response (600), filing without a valid basis (602), express abandonment by the applicant (604), or failure to respond to an examiner's inquiry (618). Revival may be possible in limited circumstances. If abandonment was unintentional, consult counsel about a petition to revive. Otherwise file a new application if protection is still needed.
Need help with LUMINIQ?
If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.
Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.
Owner
Attorney of record
The USPTO lists this attorney as the applicant's representative for correspondence on this application.
Ali R. Latifi
Ali R. Latifi Tucker & Latifi, LLP160 East 84th StreetSuite 5ENew York, NY 10028Goods and services
| Class | Description | Status | First use |
|---|---|---|---|
| 009 | Artificial intelligence software; Artificial intelligence software for analysis, data and contract analysis; Interactive software based on artificial intelligence; Software for the integration of artificial intelligence and machine learning in the field of data and data analysis; downloadable computer software and artificial intelligence computer software relating to credit and risk profiling; downloadable software and artificial intelligence software relating to the legal, procurement, finance, healthcare, financial services, credit union, biotechnology sectors; downloadable computer software and artificial intelligence computer software relating to clinical trials, non-disclosure agreements and manufacturing agreements; none of the aforesaid being for use in relation to diagnostic reagents, pharmaceutical and medical preparations, diagnostics testing, clinical diagnostics, pharmaceutical and medical preparations, substances and vaccines for human use, medical research, medical diagnostics, antigen typing, antibody identification and detection, blood typing, blood grouping, disease screening, virology screening, autoimmune disease identification, testing and detection, autoantibody testing and detection, allergy testing, or food allergy testing. | ACTIVE | — |
| 035 | Analysis of business data; management of data; data processing, data management and statistical analysis; advisory, consultancy and information services relating to all the aforesaid. | ACTIVE | — |
| 042 | Artificial intelligence and artificial intelligence software consultancy; Artificial intelligence as a service (AIAAS); Research in the field of artificial intelligence and artificial intelligence software; Technology consultation in the field of artificial intelligence; Research in the field of artificial intelligence technology, artificial intelligence related software and software platforms; Platforms for artificial intelligence as software as a service [SaaS]; Providing artificial intelligence computer programs and software on data networks and via online platforms; Software as a service [SaaS] featuring computer software and computer software platforms for artificial intelligence; IT service management [ITSM]; Enterprise content management; providing online non-downloadable software for contract and procurement management and digitally signing electronic documents and viewing, tracking, filing, sharing and storing executed electronic documents and data; provision of vendor and contract lifecycle management computer software platforms; providing non-downloadable computer software and artificial intelligence computer software relating to credit and risk profiling; providing non-downloadable software and artificial intelligence software relating to the legal, procurement, finance, healthcare, financial services, credit union, biotechnology sectors; providing non-downloadable computer software and artificial intelligence computer software relating to clinical trials, non-disclosure agreements and manufacturing agreements; providing non-downloadable cloud-computing software; cloud based software as a service [SaaS]; advisory, consultancy and information services relating all the aforesaid; none of the aforesaid being for use in relation to diagnostic reagents, pharmaceutical and medical preparations, diagnostics testing, clinical diagnostics, pharmaceutical and medical preparations, substances and vaccines for human use, medical research, medical diagnostics, antigen typing, antibody identification and detection, blood typing, blood grouping, disease screening, virology screening, autoimmune disease identification, testing and detection, autoantibody testing and detection, allergy testing, or food allergy testing. | ACTIVE | — |
Related trademarks
CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.
Prosecution history
| Date | Code | Event | What it means |
|---|---|---|---|
| Feb 11, 2026 | MAB2 | ABANDONMENT NOTICE E-MAILED - FAILURE TO RESPOND | The trademark application was abandoned because a required response or document was not filed by the deadline — usually a missed Office Action response. The application is dead unless a petition to revive is granted within a limited time. |
| Feb 11, 2026 | ABN2 | ABANDONMENT - FAILURE TO RESPOND OR LATE RESPONSE | The trademark application was abandoned because a required response or document was not filed by the deadline — usually a missed Office Action response. The application is dead unless a petition to revive is granted within a limited time. |
| Oct 28, 2025 | GNRN | NOTIFICATION OF NON-FINAL ACTION E-MAILED | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Oct 28, 2025 | GNRT | NON-FINAL ACTION E-MAILED | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Oct 28, 2025 | CNRT | NON-FINAL ACTION WRITTEN | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Oct 21, 2025 | DOCK | ASSIGNED TO EXAMINER | — |
| Oct 8, 2025 | NWOS | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED | — |
| Sep 25, 2025 | TAEA | TEAS AMENDMENT ENTERED BEFORE ATTORNEY ASSIGNED | — |
| Sep 25, 2025 | PARI | TEAS VOLUNTARY AMENDMENT RECEIVED | — |
| Jun 2, 2025 | MAFR | APPLICATION FILING RECEIPT MAILED | — |
| Jun 2, 2025 | NWAP | NEW APPLICATION ENTERED | — |